AI experts are being tasked with addressing the new coronavirus pandemic and using machine learning to mine a new dataset released by The White House.

Nearly two-thirds of hospitals are hoping to implement robotic process automation and AI technologies in the next two years, according to a new survey of healthcare executives.

AI’s impact on healthcare continues to grow, with specialties such as radiology and cardiology fully embracing the technology’s potential to modify workflows and improve patient outcomes. Family medicine physicians, however, have been slow to embrace this growing trend.

The White House has met with representatives from Amazon, Google, Facebook and other massive tech companies to see how advanced technology could help the United States slow down the spread of the new coronavirus.

Patients are on board with AI-powered skin cancer screening, according to a new study published in JAMA Dermatology. But relationships with human physicians remain a priority.

The American College of Radiology Data Science Institute (ACR DSI) has shared an AI use case for the new coronavirus, publishing it just as the World Health Organization declared COVID-19 a pandemic.

If medical AI makes a goof and causes a patient harm, the provider using the technology may be liable for malpractice. Or will the AI vendor be on the hook?

The Healthcare Information and Management Systems Society (HIMSS) has officially canceled its 2020 annual meeting in Orlando, Florida, due to continued concerns over the new coronavirus.

AI technology could be a game-changer for the diagnosis and treatment of sleep disorders, according to a new statement from the American Academy of Sleep Medicine (AASM).

AI is expected to impact radiology more than perhaps any other medical specialty. In healthcare, though, nothing is a given.

The Consumer Technology Association (CTA) has developed a new standard for the use of AI in healthcare, working with representatives from more than 50 organizations impacted by this evolving technology.

As AI continues to make a profound impact on the medical imaging industry, the FDA is hosting a two-day public workshop to discuss the benefits and risks of this powerful technology.